Listen on the go
CORRECT!
Next question
touchRESPIRATORY touchRESPIRATORY
    • FILTER YOUR SEARCH
    Content Type:
    Speciality:
    More Specialities
    Conference:
    More Conferences

    • Rhinosinusitis

    Rhinosinusitis Content

    Respiratory Infections, Airway Diseases, Allergy, Asthma, Bronchiectasis, Bronchitis, Chronic Cough, COPD, COVID-19, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Interventional Pulmonology, Lung Cancer, Paediatric Respiratory Medicine, Respiratory Tract Disorders, Pulmonary Embolism, Pulmonary Hypertension, Respiratory Intensive Care, Rhinosinusitis, Sleep Related Breathing Disorders, Lung Transplantation and Surgery, Ventilation, Lung Health, Emphysema, Rare Diseases
    What’s on the horizon for continuing medical education? Insights from touchIME

    In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

    Rhinosinusitis
    2025 Global Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Awareness Day #LetsTalkCRS
    2025 Global Chronic Rhinosinusitis with Nasal Polyp Syndrome Awareness Day #LetsTalkCRS

    On April 24, 2025, Brussels will host the 4th annual Global Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Awareness Day, organized by EUFOREA. This year’s theme, "New Ambitions of Care," focuses on enhancing understanding of CRSwNP, improving early diagnosis, and promoting better treatment strategies for those affected by this debilitating condition.

    Rhinosinusitis
    #AAAAI2025: Must-know Updates in Chronic Rhinosinusitis – Key Data from the AAAAI/WAO Joint Congress

    The 2025 AAAAI and WAO joint congress highlighted advances in chronic rhinosinusitis (CRS) treatment. Notable studies presented positive results for novel biologic therapies, including tezepelumab, depemokimab and mepolizumab for chronic rhinosinusitis with nasal polyps (CRSwNP), and dupilumab for chronic rhinosinusitis without nasal polyps (CRSsNP). These findings highlight significant advancements in symptom management, offering hope for improved patient outcomes and reduced treatment burdens.

    Airway Diseases, Rhinosinusitis, Lung Health
    Reflecting on 2024 and looking ahead to 2025: A message from Dr Xander Bertels, New Patient Advisory Board & Advocacy Manager, EUFOREA

    As 2024 comes to a close and as the new Patient Advisory Board & Advocacy Manager at EUFOREA, I have the privilege to reflect on the achievements and milestones of EUFOREA this year. With my background as a pharmacist and scientific background in precision medicine of chronic airway diseases, it is great to see efforts […]

    Rhinosinusitis
    An Algorithm for the Identification and Management of Chronic Rhinosinusitis: The European Forum for Research and Education in Allergy and Airway Diseases Pocket Guide
    Peter Hellings

    touchREVIEWS in Respiratory & Pulmonary Diseases. 2023;8(1):12–15 DOI: https://doi.org/10.17925/USRPD.2023.8.1.12

    Chronic rhinosinusitis (CRS) is a chronic sinus disease that affects between 5% and 12% of the general population.1–3 Despite substantially impacting the patient’s quality of life, it often remains underdiagnosed and undertreated.1 The European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) recently published a CRS pocket guide providing a simplified clinical care […]

    Allergy, Asthma, Rhinosinusitis
    Developed by Touch
    Isaac Schmale, AAAAI 2023: Efficacy of dupilumab for nasal polyposis in patients with aspirin-exacerbated respiratory disease
    Watch Time: 6 mins

    Dupilumab is used to manage chronic rhinosinusitis with nasal polyposis, however there is limited data regarding its use in patients with aspirin-exacerbated respiratory disease (AERD). touchRESPIRATORY caught up with Dr Isaac Schmale (University of Rochester Medical Center, Rochester, NY, USA) around the aims, eligibility, methodology and findings of his study investigating the real-world outcomes of […]

    Allergy, Asthma, Rhinosinusitis
    Developed by Touch
    Isaac Schmale, AAAAI 2023: Signs and symptoms of aspirin-exacerbated respiratory disease and its treatment paradigm
    Watch Time: 4 mins

    touchRESPIRATORY were delighted to speak with Dr Isaac Schmale (University of Rochester Medical Center, Rochester, NY, USA) around the signs and symptoms of aspirin-exacerbated respiratory disease (AERD), the incidence of AERD in people with asthma, the current treatment paradigm for AERD and the unmet needs in its treatment. The abstract ‘Real-world Outcomes of Dupilumab Therapy […]

    Rhinosinusitis
    Developed by Touch
    Peter Hellings: EUFOREA 2022 Global CRSwNP Awareness Day
    Watch Time: 7 mins

    touchRESPIRATORY were delighted to catch up with Prof Peter Hellings (Catholic University of Leuven; University Hospitals of Leuven, Leuven, Belgium) to discuss this year’s EUFOREA global CRSwNP awareness day that took place on 20 April 2022 and the importance of physician and patient awareness for improved patient outcomes. Questions Can you highlight the burden of […]

    Airway Diseases, Rhinosinusitis
    Watch Time: 35 mins
    touchIN CONVERSATION
    Minimizing the clinical burden of chronic rhinosinusitis with nasal polyposis
    CE/CME ACCREDITED Prof. Valerie Lund, Dr Sietze Reitsma Translations available:

    Watch ENT specialists discuss key considerations in optimizing the management of patients with CRSwNP.

    Learning objectives
    Learning Objectives
    • Describe the burden of disease of CRSwNP and the importance of early diagnosis
    • Explain the pathophysiology of CRSwNP and how this can guide treatment decisions
    • Summarize the clinical evidence supporting the use of current and emerging treatment options for CRSwNP
    Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
    Close Popup